Medication info

Jaytention Tablet 5/160mg

Prescription medicationExpired
Ingredient · strength
Valsartan›Strength being verifiedAmlodipine Besylate›Strength being verified
Manufacturer / importer
Vivozon Pharmaceutical Co., Ltd.
Appearance
Dark yellow oval film-coated tablet
Packaging
28 tablets/PTP (14 tablets x 2)
Approval status
Expired

MFDS item code 201308562 · Approved 2013.07.31

This product's status changed to Expired on 2023.07.31. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of essential hypertension not adequately controlled with amlodipine or valsartan monotherapy
Who uses it
Adults · Children
Adult dosage
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day, if possible (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or valsartan) before starting this medicine. However, if blood pressure is not controlled with monotherapy using either individual component, switching directly to this medicine may be considered as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or more). However, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients aged 65 years or older: Caution should be exercised when increasing the dose.
Children's dosage
The safety and efficacy of this medicine have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.

Ingredients

Manufacturer
Vivozon Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not adequately controlled with amlodipine or valsartan monotherapy

  • Essential hypertension
View approved original text

Essential hypertension can sometimes be difficult to manage with either amlodipine or valsartan alone. In such cases, using both medications together can manage blood pressure more effectively. Amlodipine works by dilating blood vessels to lower blood pressure, while valsartan prevents blood vessel constriction. The combination of these two drugs can stabilize blood pressure and reduce the risk of cardiovascular diseases. Therefore, the combination therapy of amlodipine and valsartan is effectively used for the treatment of essential hypertension.

Dosage and Administration

Adult dosage

The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day, if possible (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or valsartan) before starting this medicine. However, if blood pressure is not controlled with monotherapy using either individual component, switching directly to this medicine may be considered as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or more). However, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients aged 65 years or older: Caution should be exercised when increasing the dose.

Children's dosage

The safety and efficacy of this medicine have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.

Precautions

This medication can cause serious harm to the fetus if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately if pregnancy is confirmed. Patients with allergies to any ingredient in this medication, women who are pregnant or breastfeeding, and patients with severe kidney or liver dysfunction should not take this medication. Patients with insufficient sodium or fluid levels in the body may experience low blood pressure, so their condition should be carefully monitored before taking this medication, and blood pressure and symptoms should be closely observed during treatment. Patients with high serum potassium levels or those taking other medications that can increase potassium levels should have their potassium levels checked frequently. Patients with renal vascular issues or those who have received a kidney transplant are at risk of worsening kidney function when taking this medication, so caution is advised. If symptoms of angioedema occur, the medication should be discontinued immediately, and re-administration should be avoided. Patients with heart failure or those who have had a myocardial infarction should take this medication cautiously while regularly monitoring kidney function and blood pressure. Patients with impaired liver function should have their dosage adjusted, and it is advisable for patients with severe liver disease not to take this medication. Dizziness, headache, swelling, low blood pressure, and other side effects may occur during treatment; if symptoms are severe, consult a doctor. There may be interactions with other antihypertensive medications, potassium supplements, diuretics, non-steroidal anti-inflammatory drugs (NSAIDs), so they must inform their healthcare provider. Caution is needed when driving or operating machinery, as dizziness or fatigue may occur. This medication is not recommended for children under 18 years of age as its safety and efficacy have not been established.

Side effects

nasopharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, positional dizziness, paresthesia, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, sweating, itching, joint swelling, low back pain, arthritis, muscle cramps, fatigue, polyuria, nocturia, erectile dysfunction, edema, general swelling, facial swelling, peripheral edema, tiredness, flushing, asthenia, facial flushing, decrease in hemoglobin, decrease in hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increase in serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, kidney damage, increase in serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremors, sensory decrease, dysgeusia, peripheral neuropathy, hypertonia, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reaction, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urinary disorder, enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, neck pain, hypercholesterolemia, hypoglycemia, neurological hypersensitivity, Stevens-Johnson syndrome, arthralgia, skeletal pain, rhabdomyolysis, gingival hyperplasia, gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent exposure to air and moisture. The storage temperature should be maintained at room temperature between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

Dark yellow oval film-coated tablet

Package unit

28 tablets/PTP (14 tablets x 2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.